Phesgo® (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
for Breast Cancer

Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a targeted therapy used to treat early-stage and metastatic HER2-positive breast cancer. It combines pertuzumab, trastuzumab, and hyaluronidase to enhance absorption when given as an injection. Pertuzumab and trastuzumab are monoclonal antibodies that block HER2 receptors, slowing or stopping cancer growth.

Heart
Other top medicines used to treat Breast Cancer